Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients.

MLA

Azuma, Mizutomo, et al. “Serum Lactate Dehydrogenase Levels and Glycolysis Significantly Correlate with Tumor VEGFA and VEGFR Expression in Metastatic CRC Patients.” Pharmacogenomics, vol. 8, no. 12, Dec. 2007, pp. 1705–13. EBSCOhost, https://doi.org/10.2217/14622416.8.12.1705.

APA

Azuma, M., Shi, M., Danenberg, K. D., Gardner, H., Barrett, C., Jacques, C. J., Sherod, A., Iqbal, S., El-Khoueiry, A., Yang, D., Zhang, W., Danenberg, P. V., & Lenz, H.-J. (2007). Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. Pharmacogenomics, 8(12), 1705–1713. https://doi.org/10.2217/14622416.8.12.1705

Chicago

Azuma, Mizutomo, Michael Shi, Kathleen D Danenberg, Humphrey Gardner, Carl Barrett, Christian J Jacques, Andrew Sherod, et al. 2007. “Serum Lactate Dehydrogenase Levels and Glycolysis Significantly Correlate with Tumor VEGFA and VEGFR Expression in Metastatic CRC Patients.” Pharmacogenomics 8 (12): 1705–13. doi:10.2217/14622416.8.12.1705.